Browsing by Author Chan, A.T.C.

Showing results 1 to 10 of 10
Issue DateTitleAuthor(s)
Apr-2008A multicenter phase II trial of 3-aminopyridine-2-carboxaldehyde thiosemicarbazone (3-AP, Triapine®) and gemcitabine in advanced non-small-cell lung cancer with pharmacokinetic evaluation using peripheral blood mononuclear cellsMa, B.; Goh, B.C.; Tan, E.H.; Lam, K.C.; Soo, R. ; Leong, S.S.; Wang, L.Z. ; Mo, F.; Chan, A.T.C.; Zee, B.; Mok, T.
2008A multicenter phase II trial of 3-aminopyridine-2-carboxaldehyde thiosemicarbazone (3-AP, Triapine®) and gemcitabine in advanced non-small-cell lung cancer with pharmacokinetic evaluation using peripheral blood mononuclear cellsMa, B.; Lam, K.C.; Mo, F.; Chan, A.T.C.; Zee, B.; Mok, T.; Goh, B.C. ; Soo, R.; Wang, L.Z.; Tan, E.H.; Leong, S.S.
21-Apr-2011A novel isoform of the 8p22 tumor suppressor gene DLC1 suppresses tumor growth and is frequently silenced in multiple common tumorsLow, J.S.W. ; Tao, Q.; Ng, K.M.; Goh, H.K.; Shu, X.-S.; Woo, W.L.; Ambinder, R.F.; Srivastava, G.; Shamay, M.; Chan, A.T.C.; Popescu, N.C.; Hsieh, W.-S. 
2007Epigenetic identification of ADAMTS18 as a novel 16q23.1 tumor suppressor frequently silenced in esophageal, nasopharyngeal and multiple other carcinomasJin, H.; Wang, X.; Ying, J.; Wong, A.H.Y.; Li, H.; Lee, K.Y.; Chan, A.T.C.; Yeo, W.; Ma, B.B.Y.; Tao, Q.; Srivastava, G.; Putti, T.C. ; Lung, M.L.; Shen, Z.-Y.; Xu, L.-Y.; Langford, C.
20-Sep-2012Epigenetic therapy using belinostat for patients with unresectable hepatocellular carcinoma: A multicenter phase I/II study with biomarker and pharmacokinetic analysis of tumors from patients in the mayo phase II consortium and the cancer therapeutics research groupYeo, W.; Chung, H.C.; Chan, S.L.; Wang, L.Z. ; Lim, R.; Picus, J.; Boyer, M.; Mo, F.K.F.; Koh, J.; Rha, S.Y.; Hui, E.P.; Jeung, H.C.; Roh, J.K.; Yu, S.C.H.; To, K.F.; Tao, Q.; Ma, B.B.; Chan, A.W.H.; Tong, J.H.M.; Erlichman, C.; Chan, A.T.C.; Goh, B.C.
2002Expression of epidermal growth factor receptor in head and neck cancers correlates with clinical progression: A multicentre immunohistochemical study in the Asia-Pacific regionPutti, T.C. ; Lee, Y.S. ; To, K.F.; Tse, G.; Chan, A.T.C.; Hsu, H.C.; Lai, G.M.; Whang-Peng, J.; Millward, M.; Lee, C.S.; Lin, L.; Lin, X.
2006Functional epigenetics identifies a protocadherin PCDH10 as a candidate tumor suppressor for nasopharyngeal, esophageal and multiple other carcinomas with frequent methylationYing, J.; Li, H.; Chan, A.T.C.; Tao, Q.; Seng, T.J.; Langford, C.; Srivastava, G.; Tsao, S.W.; Putti, T. ; Murray, P.
16-Feb-2006Functional epigenetics identifies a protocadherin PCDH10 as a candidate tumor suppressor for nasopharyngeal, esophageal and multiple other carcinomas with frequent methylationYing, J.; Li, H.; Seng, T.J.; Langford, C.; Srivastava, G.; Tsao, S.W.; Putti, T. ; Murray, P.; Chan, A.T.C.; Tao, Q. 
2007Irofulven as first line therapy in recurrent or metastatic gastric cancer: A phase II multicenter study by the Cancer Therapeutics Research Group (CTRG)Yeo, W.; Zee, B.; Ma, B.; Lam, K.C.; Mo, F.K.F.; Ng, E.K.W.; Ho, R.; Chan, A.T.C.; Yeo, W.; Boyer, M.; Clarke, S.; Beale, P.; Chung, H.C.; Roh, J.K.; Rha, S.Y.; Jeung, H.C.; Ong, S.Y.K.; Lim, R.; Soo, R.; Goh, B.C. 
Sep-2005Liver resection after irinotecan, 5-fluorouracil, and folinic acid for patients with unresectable colorectal liver metastases: A multicenter phase II study by the cancer therapeutic research groupHo, W.M.; Ma, B.; Mok, T.; Yeo, W.; Lai, P.; Lim, R.; Koh, J.; Wong, Y.Y.; King, A.; Leow, C.K. ; Chan, A.T.C.